5
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Local heparin delivery for prevention of second in-stent restenosis. Acute and long-term results in 47 consecutive cases

, , &
Pages 181-184 | Published online: 10 Jul 2009

  • Savage MP, Fishman DL, Schatz RA et al. Long-term angiographic and clinical outcome after implantation of a balloon-expandable stent in the native coronary circulation. Palmaz-Schatz Stent Study Group. J Am Coll Cardiol 1994; 24: 1207-1212.
  • Fenton SH, Fishman DL, Savage MP et al. Long-term angiographic and clinical outcome after implantation of balloonexpandable stents in aortocoronary saphenous vein grafts. Am J Cardiol 1994; 74: 1187-1191.
  • Schomig A, Kastrati A, Mudra H et al. Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure. Circulation 1994; 90: 2716-2724.
  • Vrolix M, Piessens J. Usefulness of the Wiktor stent for treatment of threatened or acute closure complicating coronary angioplasty: the European Wiktor Stent Study Group. Am J Cardiol 1994; 73: 737-741.
  • Medina A, Melian F, Suarez de Leso J et al. Effectiveness of coronary stenting for the treatment of chronic total occlusion in angina pectoris. Am J Cardiol 1994; 73: 1222-1224.
  • Wong SC, Baim DS, Schatz RA et al. Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter US Palmaz-Schatz stent experience. The Palmaz-Schatz Stent Study Group. J Am Coll Cardiol 1995; 26: 704-712.
  • Baim DS, Levine MJ, Leon MB et al. Management of restenosis within the Palmaz-Schatz coronary stent (the US multicenter experience). The US Palmaz-Schatz Stent Investigators. Am J Cardiol 1993; 71: 364-366.
  • Macander PJ, Roubin GS, Agrawal SK et al. Balloon angioplasty for treatment of in-stent restenosis: feasibility, safety and efficacy. Cathet Cardiovasc Diagn 1994; 32: 125-131.
  • Mehran R, Mintz GS, Popma JJ et al. Mechanisms and results of balloon angioplasty for the treatment of in-stent restenosis. Am J Cardiol 1996; 78: 618-622.
  • Yokoi H, Kimura T, Nobuyoshi M. Palmaz-Schatz coronary stent restenosis: pattern and management. J Am Coll Cardiol 1994; 23: 117A.
  • Clowes AW, Clowes MM. Kinetics of cellular proliferation after arterial injury. Inhibition of smooth muscle cell growth by heparin. Lab Invest 1985; 52: 611.
  • Tina Au YP, Kenagy RD, Clowes MM, Clowes AW. Mechanisms of inhibition by heparin of vascular smooth muscle cell proliferation and migration. Haemostasis 1993; 3: 177-182.
  • Ellis SG, Roubin GS, Wilentz J, Douglas JS Jr, King SB 111. Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart) 1989; 117: 777-782.
  • Fram DB, Mitchel JF, Eldin AM et al. Intramural delivery of 3H-heparin with a new site-specific drug-delivery system -the Dispatch catheter. J Am Coll Cardiol 1994; 186A: 1A-484A.
  • Camenzind E, Kint PP, Di Mario G et al. lntracoronary heparin delivery in humans. Acute feasibility and longterm results. Circulation 1995; 92: 2463-2472.
  • McKay RG, Fram DB, Hirst JA et al. Treatment of intracoronary thrombus with local urokinase infusion using a new, site-specific drug-delivery system: the Dispatch catheter. Cathet Cardiovasc Diagn 1994; 33: 181-188.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.